KRI1 Antikörper (N-Term)
Kurzübersicht für KRI1 Antikörper (N-Term) (ABIN5517831)
Target
Alle KRI1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- KRI1 Antibody - N-terminal region
-
Sequenz
- FAARYNRYRE REELQRLKDR YGDRDSSSDS SSESDSSDER VEFDPQQERD
-
Aufreinigung
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human KRI1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under AAP78137-100UG
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- prevent freeze-thaw cycles
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
- KRI1 (KRI1 Homolog (KRI1))
-
Andere Bezeichnung
- KRI1
-
Hintergrund
-
Background Information: This gene overlaps with the gene for cysteine endopeptidase AUT-like 4 in a head-to-tail orientation.
Gene Name: KRI1 homolog
Protein Name: protein KRI1 homolog
-
Molekulargewicht
- 78 kDa
-
Gen-ID
- 65095
-
NCBI Accession
- NP_075384
-
UniProt
- Q8N9T8
Target
-